3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
1
Supratentorial Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Postoperative Hemorrhage
1
Oropharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia
1
Hodgkin Disease
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Anus Neoplasms
1
Agnosia
1
Interventions
Magnetic Resonance Spectroscopy
18
pembrolizumab
16
Specimen Handling
15
Cisplatin
14
Carboplatin
9
Platinum
8
Cetuximab
8
1,2-diaminocyclohexaneplatinum II citrate
8
Radiotherapy, Intensity-Modulated
7
Radiation
7
Paclitaxel
7
Biopsy
7
Taxes
6
Radiotherapy
6
cemiplimab
4
X-Rays
4
Standard of Care
4
Nivolumab
4
Drug Therapy
4
(225)Ac-DOTA-c(RGDyK)
4
durvalumab
3
Ultrasonography
3
Surgical Procedures, Operative
3
Sentinel Lymph Node Biopsy
3
Observation
3
Immunoglobulin G
3
Disulfides
3
ipatasertib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Epinephrine
×
1 year
×
Clear all
No trials found.